Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
about
Multiple Functions of Ten-eleven Translocation 1 during TumorigenesisDecreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysisDecreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma.Potential options for managing LOX+ ER- breast cancer patientsCharacterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significanceLysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer.Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.Ten-eleven translocation 1 dysfunction reduces 5-hydroxymethylcytosine expression levels in gastric cancer cells.Integrating 5hmC and gene expression data to infer regulatory mechanisms.Isocitrate dehydrogenase 1-snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability.Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression.Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
P2860
Q26740522-E04EE2E6-51BD-43C4-8B77-5A2810AE8099Q30240261-5BB34CAE-875B-4B17-B67D-7E12B03DB26AQ36958399-D2336BE6-E2B0-47E5-9A8D-52A65C1DFD4EQ37362796-4AD2A463-03A6-498A-B43A-FB353AEBDDE1Q37480308-0C0FD202-F684-4A92-B5F1-40E33378E4AFQ41701650-026D77B9-9354-4619-880C-E330273E4B08Q41868979-368C1F9B-2AA5-4EF9-8823-20716E7D9D73Q47093879-2CBF91A6-4029-4C79-B300-47F7C2AC9C3DQ47302653-94B14ABB-A72B-422F-9192-1378FAA023E4Q54981076-4334BE1C-46DD-481A-95A0-716DCFA29237Q55024653-3EDD0196-C7FF-4F9F-B526-D5E46B6B6461Q58797571-F65B5BF1-AAB2-4E32-ABE7-DBCE161C4A41
P2860
Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Reduction of global 5-hydroxym ...... for an ER/PR-negative subtype.
@en
type
label
Reduction of global 5-hydroxym ...... for an ER/PR-negative subtype.
@en
prefLabel
Reduction of global 5-hydroxym ...... for an ER/PR-negative subtype.
@en
P2093
P2860
P1476
Reduction of global 5-hydroxym ...... for an ER/PR-negative subtype
@en
P2093
Chien-Chou Chen
Chien-Hsun Chen
Guan-Cheng Li
Hong-Tai Chang
Huei-Han Liou
Hui-Hwa Tseng
Hui-Yu Chang
Hung-Wei Pan
Jer-Shyung Huang
Luo-Ping Ger
P2860
P2888
P304
P356
10.1007/S10549-015-3525-X
P407
P577
2015-08-08T00:00:00Z
P6179
1045409576